SI
Shoulder Innovations, Inc.NYSEHealthcare$14.60-0.54%ClosedMarket Cap: $301.5M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.93
P/S
6.32
EV/EBITDA
-7.52
DCF Value
$-0.29
FCF Yield
-12.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.5%
Operating Margin
-55.6%
Net Margin
-85.3%
ROE
-89.5%
ROA
-23.8%
ROIC
-14.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $14.4M | $-7.8M | $-0.38 |
| FY 2025 | $47.3M | $-40.4M | $-0.00 |
| Q3 2025 | $11.8M | $-8.7M | $-0.06 |
| Q2 2025 | $11.0M | $-19.2M | $-0.95 |
Analyst Ratings
View AllBTIGBuy
2026-03-11Morgan StanleyOverweight
2025-12-02Piper SandlerOverweight
2025-11-12BTIGBuy
2025-09-09Trading Activity
Insider Trades
View AllPoints Jeffrey S.officer: Chief Financial Officer
BuyTue Mar 17
Points Jeffrey S.officer: Chief Financial Officer
SellTue Mar 17
BUCKMAN PAULdirector
SellTue Mar 17
BUCKMAN PAULdirector
SellTue Mar 17
BUCKMAN PAULdirector
SellTue Mar 17
Latest News
Silicon Metals Corp. Announces Share Consolidation and Record DateNewsfile Corp · Wed Apr 01
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
-4.26
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.